IP Library › Granted Patent US 8,262,722
Granted Patent B2
US 8,262,722 · App. 12/613,480 · Granted Sep 11, 2012

Endoprosthesis

Assignee: BIOTRONIK VI Patent AG
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,262,722
App. No.
12/613,480
Granted
Sep 11, 2012
Kind
B2
Abstract

An endoprosthesis, in particular an intraluminal endoprosthesis, for example a stent, having a base body composed at least partially of a metallic material, and having a functional element which is attached to the base body or imbedded therein and which contains material that is radiopaque and/or X-ray opaque and has a different material composition, at least in a portion of its volume, compared to the material of the base body. To avoid contact corrosion and undesired corrosion, the functional element is provided with a barrier layer which electrically insulates the radiopaque and/or X-ray opaque material from the base body.

Claims (18)

1. An endoprosthesis having a base body composed at least partially of a metallic material, and having a functional element which is attached to the base body or imbedded therein and which contains material that is radiopaque and/or X-ray opaque and has a different material composition, at least in a portion of its volume, compared to the material of the base body, characterized in that:

the functional element comprises two through openings and a barrier layer which electrically insulates the radiopaque and/or X-ray opaque material from the base body; and

the base body comprises two finger elements that extend entirely through the through openings on a same functional element and are bent or rotated outward from the through openings.

2. The endoprosthesis according to claim 1 , characterized in that the barrier layer completely encloses the radiopaque or X-ray opaque material.

3. The endoprosthesis according to claim 1 , characterized in that the barrier layer contains one or more materials selected from the group consisting of a parylene, parylene C, polyzene F, silicone, gycocalyx, diamond-like carbon (DLC), a cyanoacrylate, methyl-2-cyanoacrylate, n-butyl cyanoacrylate, 2-octyl-cyanoacrylate, and titanium dioxide.

4. The endoprosthesis according to claim 1 , characterized in that the barrier layer encloses a volume of the radiopaque and/or X-ray opaque material of one or more adjacent functional elements with a cross-sectional area of at least approximately 200 μm by approximately 100 μm, and/or with an extension in one direction of at least approximately 300 μm, and/or with an extension corresponding to two pixels resolution of angiography devices.

5. The endoprosthesis according to claim 1 , characterized in that the base body contains a biodegradable material comprising magnesium and/or a magnesium alloy.

6. The endoprosthesis according to claim 1 , characterized in that the functional element together with the surrounding barrier layer has a wire-shaped design.

7. The endoprosthesis according to claim 1 , characterized in that the two finger elements are made of the same material as the base body.

8. The endoprosthesis according to claim 5 , characterized in that the two finger elements are made of the same material as the base body.

9. An endoprosthesis having a base body composed at least partially of a metallic material, and having a functional element which is attached to the base body or imbedded therein and which contains material that is radiopaque and/or X-ray opaque and has a different material composition, at least in a portion of its volume, compared to the material of the base body, characterized in that:

the functional element comprises a hollow cylinder with an opaque core and a barrier layer that completely encloses the core, which electrically insulates the radiopaque and/or X-ray opaque material from the base body, the functional element further comprising a circumferential groove on a lateral surface; and

the base body comprises a forked element comprising an annular section that is situated in the circumferential groove.

10. The endoprosthesis according to claim 9 , characterized in that the barrier layer contains one or more materials selected from the group consisting of a parylene, parylene C, polyzene F, silicone, gycocalyx, diamond-like carbon (DLC), a cyanoacrylate, methyl-2-cyanoacrylate, n-butyl cyanoacrylate, 2-octyl-cyanoacrylate, and titanium dioxide.

11. The endoprosthesis according to claim 9 , characterized in that the barrier layer encloses a volume of the radiopaque and/or X-ray opaque material of one or more adjacent functional elements with a cross-sectional area of at least approximately 200 μm by approximately 100 μm, and/or with an extension in one direction of at least approximately 300 μm, and/or with an extension corresponding to two pixels resolution of angiography devices.

12. The endoprosthesis according to claim 9 , characterized in that the base body contains a biodegradable material comprising magnesium and/or a magnesium alloy.

13. The endoprosthesis according to claim 12 , characterized in that the forked element is made of the same material as the base body.

14. The endoprosthesis according to claim 9 , characterized in that the forked element is made of the same material as the base body.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2018
From: BIOTRONIK VI PATENT AG
To: BIOTRONIK AG
Reel/Frame 045853/0610 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2009
From: KLOCKE, BJOERN, DR.; RIEDMUELLER, JOHANNES
To: BIOTRONIK VI PATENT AG
Reel/Frame 023485/0275 →
Priority Claims (1)
DE 10 2008 043 642 · Nov 11, 2008 · national
Continuity (1)
Related Publication 20100121432A1 · May 13, 2010